CRNX News and Press, Crinetics Pharmaceuticals Inc. From 09/02/21

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc . (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today a...

– Commenced dosing in Phase 3 PATHFNDR-1 study – – Phase 1 single-ascending dose data demonstrate the dose-dependent and clinically-significant pharmacodynamic effects of CRN04894 – – Phase 1 data for CRN04777 expected in September ...

CRN04894 Phase 1 Study Progressing to Multiple Ascending Dose Cohorts Management Hosting Webcast and Conference Call Today to Discuss Findings at 4:30 p.m. Eastern Time SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinica...

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced toda...

- If successful, paltusotine would offer acromegaly patients a once-daily oral treatment option - SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and comm...

Gainers: Geron (GERN) +22%, AnPac Bio-Medical Science (ANPC) +20%, CureVac (CVAC) +13%, Crinetics Pharmaceuticals (CRNX) +7%, Seres Therapeutics (MCRB) +7%.Losers: Orphazyme (ORPH) -41%, Athira Pharma (ATHA) -41%, Chinook Therap...

yucelyilmaz/iStock via Getty Images Supreme Court decision on ACA is a positive for Centene  Managed care organizations such as Centene (CNC) and Molina (MOH) rose yesterday in response to the Supreme Court decision to uphold the Affordable Care Act. Bernstein analyst Lance Wikes se...

CAI International (CAI) +46% on merger deal with Mitsubishi HC Capital.Sykes Enterprises (SYKE) +30% on being acquired by Sitel group for $54.0 per share.AnPac Bio-Medical Science (ANPC) +22% after securing first disease treatment patent in U.S.Geron Corporation (GERN) +20% ...

Crinetics Pharmaceuticals (CRNX) announces the appointment of Garlan Adams to the newly created role of general counsel.Adams brings to Crinetics more than two decades of experience managing legal and compliance matters associated with the development and commercialization...

Crinetics Pharmaceuticals (CRNX): Q1 GAAP EPS of -$0.69 misses by $0.04.Cash, cash equivalents and investments of $150.7MPress Release For further details see: Crinetics Pharmaceuticals EPS misses by $0.04